Abstract Details
| Ruediger Hilker, MD (University Hospital, Department of Neurology) | No disclosure on file |
| Carsten Eggers (Biogen Idec GmbH) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Norbert Bruggemann, MD | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Halinder Mangat, MD | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Hartwig Siebner, MD (Christian-albrechts-university Kiel) | No disclosure on file |
| Gereon Fink (Forschungszentrum Julich) | No disclosure on file |
| Christine Klein, MD (University of Luebeck) | Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care. |